International Consensus Guideline on Delineation of the Clinical Target Volumes (CTV) at Different Dose Levels for Nasopharyngeal Carcinoma (2024 Version).
Shao-Jun Lin, Qiao-Juan Guo, Qin Liu, Wai-Tong Ng, Yong Chan Ahn, Hussain AlHussain, Annie W Chan, James Chow, Melvin Chua, June Corry, Fei Han, Vincent Grégoire, Kevin J Harrington, Chao-Su Hu, Kenneth Jensen, Johannes A Langendijk, Quynh Thu Le, Nancy Y Lee, Victor Lee, Jin-Ching Lin, Jun Ma, William M Mendenhall, Brian O'Sullivan, Enis Ozyar, David I Rosenthal, Yun-Gan Tao, Ren-Sheng Wang, Joseph Wee, Zhi-Yuan Xu, Jun-Lin Yi, Sue S Yom, Dai-Ming Fan, Hai-Qiang Mai, Jian-Ji Pan, Anne W M Lee
{"title":"International Consensus Guideline on Delineation of the Clinical Target Volumes (CTV) at Different Dose Levels for Nasopharyngeal Carcinoma (2024 Version).","authors":"Shao-Jun Lin, Qiao-Juan Guo, Qin Liu, Wai-Tong Ng, Yong Chan Ahn, Hussain AlHussain, Annie W Chan, James Chow, Melvin Chua, June Corry, Fei Han, Vincent Grégoire, Kevin J Harrington, Chao-Su Hu, Kenneth Jensen, Johannes A Langendijk, Quynh Thu Le, Nancy Y Lee, Victor Lee, Jin-Ching Lin, Jun Ma, William M Mendenhall, Brian O'Sullivan, Enis Ozyar, David I Rosenthal, Yun-Gan Tao, Ren-Sheng Wang, Joseph Wee, Zhi-Yuan Xu, Jun-Lin Yi, Sue S Yom, Dai-Ming Fan, Hai-Qiang Mai, Jian-Ji Pan, Anne W M Lee","doi":"10.1016/j.ijrobp.2025.05.019","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and purpose: </strong>Radiotherapy planning for nasopharyngeal carcinoma (NPC) is one of the most challenging tasks for radiation oncologists due to the notoriously narrow therapeutic margin. The first International Guideline (IG-2018 Version) has served as a practical guide for contouring clinical target volumes (CTV). With increasing data on locoregional extension patterns and outcomes from studies on optimizing CTV and doses, an updated International Guideline is pressingly needed to provide a reference for enhancing precision.</p><p><strong>Methods and materials: </strong>A comprehensive literature review was conducted to assess existing guidelines and emerging data related to contouring. A preliminary questionnaire was distributed to 30 international experts (from 26 centers in 14 countries/regions) with extensive experience in NPC treatment, aiming to capture diverse practices and opinions. Following initial voting and iterations, a comprehensive survey was prepared for consensus building.</p><p><strong>Results: </strong>The initial questionnaire revealed marked variations in clinical practices related to CTV contouring and prescribed doses among experts. The final Delphi survey consisted of 58 questions: 20 (34%) parameters attained consensus (≥ 75% agreement) and 32 (55%) attained agreement (60-74% agreement). In the current guideline (IG-2024), 36 parameters involved changes/clarifications compared to IG-2018. The major differences focus on the use of post-induction chemotherapy GTV (except in patients with advanced extranodal extension) for CTV(p/n) to 70 Gy equivalent, stepwise refinement of elective coverage to ipsilateral anatomical structures for eccentric primary tumor, selective coverage of nodal levels, and a lower elective dose of 50 Gy equivalent.</p><p><strong>Conclusion: </strong>Midst the challenges of diverging practices, a comprehensive consensus guideline is devised based on updated evidence and collective agreement among international experts. This serves as a practical reference for optimal target coverage at different dose levels to maximize locoregional control while minimizing toxicities, and guiding principles for generating automated contouring programs to enhance standardization.</p>","PeriodicalId":14215,"journal":{"name":"International Journal of Radiation Oncology Biology Physics","volume":" ","pages":""},"PeriodicalIF":6.4000,"publicationDate":"2025-05-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Radiation Oncology Biology Physics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.ijrobp.2025.05.019","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background and purpose: Radiotherapy planning for nasopharyngeal carcinoma (NPC) is one of the most challenging tasks for radiation oncologists due to the notoriously narrow therapeutic margin. The first International Guideline (IG-2018 Version) has served as a practical guide for contouring clinical target volumes (CTV). With increasing data on locoregional extension patterns and outcomes from studies on optimizing CTV and doses, an updated International Guideline is pressingly needed to provide a reference for enhancing precision.
Methods and materials: A comprehensive literature review was conducted to assess existing guidelines and emerging data related to contouring. A preliminary questionnaire was distributed to 30 international experts (from 26 centers in 14 countries/regions) with extensive experience in NPC treatment, aiming to capture diverse practices and opinions. Following initial voting and iterations, a comprehensive survey was prepared for consensus building.
Results: The initial questionnaire revealed marked variations in clinical practices related to CTV contouring and prescribed doses among experts. The final Delphi survey consisted of 58 questions: 20 (34%) parameters attained consensus (≥ 75% agreement) and 32 (55%) attained agreement (60-74% agreement). In the current guideline (IG-2024), 36 parameters involved changes/clarifications compared to IG-2018. The major differences focus on the use of post-induction chemotherapy GTV (except in patients with advanced extranodal extension) for CTV(p/n) to 70 Gy equivalent, stepwise refinement of elective coverage to ipsilateral anatomical structures for eccentric primary tumor, selective coverage of nodal levels, and a lower elective dose of 50 Gy equivalent.
Conclusion: Midst the challenges of diverging practices, a comprehensive consensus guideline is devised based on updated evidence and collective agreement among international experts. This serves as a practical reference for optimal target coverage at different dose levels to maximize locoregional control while minimizing toxicities, and guiding principles for generating automated contouring programs to enhance standardization.
期刊介绍:
International Journal of Radiation Oncology • Biology • Physics (IJROBP), known in the field as the Red Journal, publishes original laboratory and clinical investigations related to radiation oncology, radiation biology, medical physics, and both education and health policy as it relates to the field.
This journal has a particular interest in original contributions of the following types: prospective clinical trials, outcomes research, and large database interrogation. In addition, it seeks reports of high-impact innovations in single or combined modality treatment, tumor sensitization, normal tissue protection (including both precision avoidance and pharmacologic means), brachytherapy, particle irradiation, and cancer imaging. Technical advances related to dosimetry and conformal radiation treatment planning are of interest, as are basic science studies investigating tumor physiology and the molecular biology underlying cancer and normal tissue radiation response.